Enliven Therapeutics Inc. (ELVN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $29.62
• Market Cap: $1.74B
• EPS: $-1.81
• 52-Week High: $30.22
• 52-Week Low: $13.30

Market Sentiment

Enliven Therapeutics Inc. currently has a Neutral sentiment score of -0.09.

About Enliven Therapeutics Inc.

None

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Enliven Therapeutics Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ELVN pay dividends?

Enliven Therapeutics Inc. (ELVN) does not currently pay a regular dividend.

What is ELVN's market cap?

Enliven Therapeutics Inc. (ELVN) has a market capitalization of $1.74B with a current stock price of $29.62.